Enter your login e-mail to the account
Search
- The current possibilities of pharmacotherapy and prevention for infections of lower urinary tract
PharmDr. Eva Kráľová, PhD., PharmDr. Ivana Granatierová
(6/2014, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - Multiple sclerosis – maternity and breastfeeding
MUDr. Olga Zapletalová
(6/2019, Interdisciplinary consilium )
- NCREASED DAYTIME SOMNOLENCE AND ATTACKS OF SUDDEN FALLING ASLEEP IN PATIENTS WITH PARKINSON’S DISEASE
MUDr. Martin Bareš, Ph.D.
(2/2004, Review articles )
- Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Migraine and multiple sclerosis
MUDr. Rudolf Kotas, Ph.D., MUDr. Marta Vachová
(6/2023, Review articles ) - Fingolimod in clinical practice: case reports
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(6/2014, Case reports ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Nejčastější chyby a omyly v diagnostice a terapii myasthenia gravis
prof. MUDr. Zdeněk Ambler, DrSc. , MUDr. Jiří Piťha
(5/2004, Review articles ) - Multiple sclerosis – maternity and breastfeeding
MUDr. Olga Zapletalová
(1/2019, Review articles ) - Improving gait in patients with multiple sclerosis
Mgr. Klára Novotná, Ph.D., MUDr. Jana Lízrová Preiningerová
(3/2022, From the boundary of neurology ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - New treatment options for pediatric patients with multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(3/2019, Review articles ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Teriflunomide in treating relapsing-remitting multiple sclerosis – immunomodulatory mechanisms
doc. MUDr. Vojtěch Thon, Ph.D.
(1/2016, Pharmacotherapy ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- COVID-19 in children
doc. MUDr. Margita Špaleková, PhD.
(5/2020, Review articles )
- Treatment options in multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(1/2007, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Systemic amyloidosis
MUDr. Lenka Zahradová, Ph.D.
(6/2016, Spectrum ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - Treatment of newly diagnosed multiple myeloma
Doc. MUDr. Ľubica Harvanová, PhD., MUDr. Kristína Nemergutová, MUDr. Iveta Simančíková, PhD., MUDr. Ladislav Sopko, PhD., prof. MUDr. Angelika Bátorovová, CSc.
(6/2022, Main topic ) - Pomalidomide in heavily pretreated patient with multiple myeloma: a case report
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2018, Original works & case studies ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Cardiovascular complications caused by treatment of hematologic malignancies
Prof. MUDr. Beata Mladosievičová, PhD.
(4/2017, Review articles )
- Intravenous immunoglobulin in therapy of pemphigus vulgaris
prof. MUDr. Danka Švecová, PhD.
(4/2015, Review articles ) - Antimalarial agents in dermatology
prof. MUDr. Danka Švecová, PhD., prof. MUDr. Ján Murín, CSc.
(2/2021, Drugs & drug classes )
- Immunotherapy in outpatient practice – what we can expect from chemical immunomodulatory drugs?
doc. MUDr. Martin Hrubiško, PhD.
(1/2009, Review articles ) - BACTERIAL IMMUNOMODULATORS – SUPPORT OF NATURAL BODY DEFENCE MECHANISMS
doc. MUDr. Martin Hrubiško, PhD.
(2/2008, Review articles )
- N-acetylcysteine in current clinical praxis
MUDr. Jiří Slíva, Ph.D.
(3/2016, Drug profile ) - The current possibilities of pharmacotherapy and prevention for infections of lower urinary tract
PharmDr. Eva Kráľová, PhD., PharmDr. Ivana Granatierová
(2-3/2014, Current pharmacotherapy ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy ) - Overview of H1 antihistamines intended not only for seasonal pollen allergy
prof. PharmDr. Martin Doležal, Ph.D.
(2/2013, Current pharmacotherapy )
- The using of mesenchymal stem cells in treatment of Type I. diabetes
prof. MUDr. Jozef Radoňak, CSc., doc. MUDr. Jana Kaťuchová, PhD., MUDr. Tomáš Hildebrand
(3/2012, Review articles )